Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 21, 2012
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - Market Wire
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - Market Wire
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - Market Wire
[ Wed, Mar 21st 2012
] - Market Wire
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI
Matt Miksic Maintained (ABT) at Hold with Increased Target to $60 on, Mar 21st, 2012
Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $56 to $60 on, Mar 21st, 2012.
Matt has made no other calls on ABT in the last 4 months.
There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matt
- Brittany Henderson of "Deutsche Bank" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Monday, March 19th, 2012
Similar Stocks and Investing Articles
[ Tue, Mar 20th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI
[ Fri, Mar 16th 2012
] - WOPRAI
[ Fri, Mar 16th 2012
] - WOPRAI
[ Wed, Mar 14th 2012
] - WOPRAI
[ Tue, Mar 13th 2012
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI
[ Fri, Mar 02nd 2012
] - WOPRAI
[ Fri, Mar 02nd 2012
] - WOPRAI